Clinical trial suggests benefit of adjuvant chemo-immunotherapy in resected stage IB–IIIA NSCLC
Updated on: October 05,2025
0
Clinical trial suggests benefit of adjuvant chemo-immunotherapy in resected stage IB–IIIA NSCLC
Updated on:October 05,2025
0
